Performance of COPD population screener questionnaire in COPD screening: a validation study and meta-analysis

This study aimed to validate the chronic obstructive pulmonary disease (COPD) Population Screener (COPD-PS) questionnaire as a screening tool in a cohort of Chinese subjects who underwent a health examination, and to summarise its overall performance through a meta-analysis. We enrolled 997 subjects...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanhui Gu, Ying Zhang, Qian Wen, Yao Ouyang, Yongchun Shen, He Yu, Chun Wan, Jing Zhu, Fuqiang Wen
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Annals of Medicine
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2021.1949486
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849340481252622336
author Yanhui Gu
Ying Zhang
Qian Wen
Yao Ouyang
Yongchun Shen
He Yu
Chun Wan
Jing Zhu
Fuqiang Wen
author_facet Yanhui Gu
Ying Zhang
Qian Wen
Yao Ouyang
Yongchun Shen
He Yu
Chun Wan
Jing Zhu
Fuqiang Wen
author_sort Yanhui Gu
collection DOAJ
description This study aimed to validate the chronic obstructive pulmonary disease (COPD) Population Screener (COPD-PS) questionnaire as a screening tool in a cohort of Chinese subjects who underwent a health examination, and to summarise its overall performance through a meta-analysis. We enrolled 997 subjects aged ≥40 years who underwent a health examination, both lung function and COPD-PS data were collected. The screening performance of COPD-PS was evaluated with a receiver operating characteristic (ROC) curve analysis, using the area under the curve (AUC) to assess the screening accuracy. A standard diagnostic meta-analysis was used to summarise the screening performance of COPD-PS for COPD. Of the 997 subjects, 157 were identified as having COPD. The COPD-PS score was significantly higher in COPD patients than controls (5.03 ± 5.11 vs. 2.72 ± 1.80, p < .001). At a cut-off of 4, the sensitivity and specificity of COPD-PS for identifying COPD were 74.52 and 70.24%, respectively, with an AUC of 0.79. Eight studies (including this study) were included in this meta-analysis. The pooled estimates for COPD-PS were as follows: sensitivity of 0.66 (95% CI: 0.47–0.63), specificity of 0.86 (95% CI: 0.84–0.89), positive likelihood ratio of 3.00 (95% CI: 1.65–5.47), negative likelihood ratio of 0.43 (95% CI: 0.35–0.52) and diagnostic odds ratio of 7.24 (95% CI: 3.91–13.40). The AUC of the summary ROC curve was 0.78. COPD-PS appears to be a useful tool for screening individuals with a high risk of COPD and guiding the selection of individuals for subsequent spirometry examination.KEY MESSAGESCOPD-PS is a simple and useful method to screen COPD.The combination of COPD-PS with other tools may improve the screen performance.
format Article
id doaj-art-5166f8d8f79f411bbdd499c9699c965f
institution Kabale University
issn 0785-3890
1365-2060
language English
publishDate 2021-01-01
publisher Taylor & Francis Group
record_format Article
series Annals of Medicine
spelling doaj-art-5166f8d8f79f411bbdd499c9699c965f2025-08-20T03:43:55ZengTaylor & Francis GroupAnnals of Medicine0785-38901365-20602021-01-015311199120710.1080/07853890.2021.1949486Performance of COPD population screener questionnaire in COPD screening: a validation study and meta-analysisYanhui Gu0Ying Zhang1Qian Wen2Yao Ouyang3Yongchun Shen4He Yu5Chun Wan6Jing Zhu7Fuqiang Wen8Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, ChinaDepartment of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, ChinaHealth Management Center, Affiliated Hospital of Zunyi Medical University, Zunyi, ChinaDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, ChinaDepartment of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, ChinaDepartment of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, ChinaDepartment of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, ChinaDepartment of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, ChinaDepartment of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, ChinaThis study aimed to validate the chronic obstructive pulmonary disease (COPD) Population Screener (COPD-PS) questionnaire as a screening tool in a cohort of Chinese subjects who underwent a health examination, and to summarise its overall performance through a meta-analysis. We enrolled 997 subjects aged ≥40 years who underwent a health examination, both lung function and COPD-PS data were collected. The screening performance of COPD-PS was evaluated with a receiver operating characteristic (ROC) curve analysis, using the area under the curve (AUC) to assess the screening accuracy. A standard diagnostic meta-analysis was used to summarise the screening performance of COPD-PS for COPD. Of the 997 subjects, 157 were identified as having COPD. The COPD-PS score was significantly higher in COPD patients than controls (5.03 ± 5.11 vs. 2.72 ± 1.80, p < .001). At a cut-off of 4, the sensitivity and specificity of COPD-PS for identifying COPD were 74.52 and 70.24%, respectively, with an AUC of 0.79. Eight studies (including this study) were included in this meta-analysis. The pooled estimates for COPD-PS were as follows: sensitivity of 0.66 (95% CI: 0.47–0.63), specificity of 0.86 (95% CI: 0.84–0.89), positive likelihood ratio of 3.00 (95% CI: 1.65–5.47), negative likelihood ratio of 0.43 (95% CI: 0.35–0.52) and diagnostic odds ratio of 7.24 (95% CI: 3.91–13.40). The AUC of the summary ROC curve was 0.78. COPD-PS appears to be a useful tool for screening individuals with a high risk of COPD and guiding the selection of individuals for subsequent spirometry examination.KEY MESSAGESCOPD-PS is a simple and useful method to screen COPD.The combination of COPD-PS with other tools may improve the screen performance.https://www.tandfonline.com/doi/10.1080/07853890.2021.1949486Chronic obstructive pulmonary diseasechronic obstructive pulmonary disease population screenerscreeningmeta-analysis
spellingShingle Yanhui Gu
Ying Zhang
Qian Wen
Yao Ouyang
Yongchun Shen
He Yu
Chun Wan
Jing Zhu
Fuqiang Wen
Performance of COPD population screener questionnaire in COPD screening: a validation study and meta-analysis
Annals of Medicine
Chronic obstructive pulmonary disease
chronic obstructive pulmonary disease population screener
screening
meta-analysis
title Performance of COPD population screener questionnaire in COPD screening: a validation study and meta-analysis
title_full Performance of COPD population screener questionnaire in COPD screening: a validation study and meta-analysis
title_fullStr Performance of COPD population screener questionnaire in COPD screening: a validation study and meta-analysis
title_full_unstemmed Performance of COPD population screener questionnaire in COPD screening: a validation study and meta-analysis
title_short Performance of COPD population screener questionnaire in COPD screening: a validation study and meta-analysis
title_sort performance of copd population screener questionnaire in copd screening a validation study and meta analysis
topic Chronic obstructive pulmonary disease
chronic obstructive pulmonary disease population screener
screening
meta-analysis
url https://www.tandfonline.com/doi/10.1080/07853890.2021.1949486
work_keys_str_mv AT yanhuigu performanceofcopdpopulationscreenerquestionnaireincopdscreeningavalidationstudyandmetaanalysis
AT yingzhang performanceofcopdpopulationscreenerquestionnaireincopdscreeningavalidationstudyandmetaanalysis
AT qianwen performanceofcopdpopulationscreenerquestionnaireincopdscreeningavalidationstudyandmetaanalysis
AT yaoouyang performanceofcopdpopulationscreenerquestionnaireincopdscreeningavalidationstudyandmetaanalysis
AT yongchunshen performanceofcopdpopulationscreenerquestionnaireincopdscreeningavalidationstudyandmetaanalysis
AT heyu performanceofcopdpopulationscreenerquestionnaireincopdscreeningavalidationstudyandmetaanalysis
AT chunwan performanceofcopdpopulationscreenerquestionnaireincopdscreeningavalidationstudyandmetaanalysis
AT jingzhu performanceofcopdpopulationscreenerquestionnaireincopdscreeningavalidationstudyandmetaanalysis
AT fuqiangwen performanceofcopdpopulationscreenerquestionnaireincopdscreeningavalidationstudyandmetaanalysis